Keyphrases
Pathological Complete Response
100%
Preoperative Therapy
100%
Gastroesophageal Adenocarcinoma
100%
Gastric Adenocarcinoma
100%
Adenocarcinoma of the Esophagogastric Junction
28%
Response Group
14%
Recurrence Pattern
14%
Local-regional
14%
Resection
7%
Overall Survival
7%
High Incidence
7%
Central Nervous System
7%
Significant Risk Factors
7%
Cancer Risk
7%
Retrospective Review
7%
Cancer Mortality
7%
Adenocarcinoma
7%
Prospective Database
7%
Preoperative Chemotherapy
7%
Pathological Stage
7%
Enhanced Awareness
7%
Brain Imaging
7%
Central Nervous System Recurrence
7%
First Recurrence
7%
R0 Resection
7%
Distant Recurrence
7%
Preoperative Chemoradiation
7%
Recurrence-free Survival
7%
Recurrence Risk
7%
CNS Metastases
7%
Gastroesophageal Junction
7%
Recurrence Probability
7%
Siewert Type II
7%
Disease-specific Survival
7%
Medicine and Dentistry
Adenocarcinoma
100%
Recurrent Disease
100%
Gastroesophageal Junction
50%
Central Nervous System
20%
Surgery
20%
Malignant Neoplasm
10%
Overall Survival
10%
Awareness
10%
Chemoradiotherapy
10%
Preoperative Chemotherapy
10%
Recurrence Free Survival
10%
Identified Patient
10%
Brain Imaging
10%
Central Nervous System Metastasis
10%
Disease Specific Survival
10%
Diseases
10%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Awareness
100%
Disease Specific Survival
100%
Recurrence Free Survival
100%
Nursing and Health Professions
Recurrent Disease
100%
Adenocarcinoma
100%
Surgery
20%
Imaging
10%
Overall Survival
10%
Malignant Neoplasm
10%
Preoperative Chemotherapy
10%
Disease Specific Survival
10%
Central Nervous System Metastasis
10%
Chemoradiotherapy
10%
Recurrence Free Survival
10%
Diseases
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
100%
Recurrent Disease
100%
Malignant Neoplasm
10%
Overall Survival
10%
Chemoradiation Therapy
10%
Chemotherapy
10%
Recurrence Free Survival
10%
Central Nervous System Metastasis
10%
Disease Specific Survival
10%
Diseases
10%